AlphaYouAD
Insider selling
Atul Dandekar sold $207K of Maze Therapeutics, Inc. (MAZE) stock
Atul Dandekar, CSBO of Maze Therapeutics, Inc. (MAZE), sold 7,500 shares of MAZE stock worth $207K, per an SEC Form 4 filed Aug 31, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 28, 2026, 3 days before it was made public.
MAZE has moved -18.4% since the trade date, from $27.44 to $22.39 (Sep 21, 2026 close).
- Traded
- Aug 28, 2026
- Disclosed
- Aug 31, 2026
- Filing delay
- 3 days
- Price since
- -18.4%
- Role
- CSBO
- Source
- SEC Form 4
More MAZE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.